There is a game-changing therapy that could redefine the treatment landscape for autoimmune diseases.
In this episode, Dr. Peter Maag discusses Kyverna Therapeutics’ pioneering cell therapy work to transform autoimmune disease treatment by resetting the overactive immune system. He talks about the process of genetically modifying patient cells to target B cells, Kyverna's adaptability to regulatory feedback, clinical trials for lupus, the "Kyverna village" collaboration concept, and talent recruitment for growth.
Join us as we dive into cell therapy and the future of autoimmune disease treatment. (add link)
Click this link to the show notes, transcript, and resources: outcomesrocket.health
Outcomes Rocket